CIK: 1518466 - Address: C/o Sorrento Therapeutics, Inc., 4955 Directors Place, San Diego, CA 92121
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11188-6-6200-13
P%wins1001000050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/27/21 19:34
12/27/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADM.d124.0003New3D
12/27/21 19:34
12/27/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADS.d-185.880-3-503D
9/28/21 17:37
9/27/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADM.d892.110423D
9/28/21 17:37
9/27/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADS.d-3408.020-42-933D
9/14/21 17:00
9/13/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADM.d283.50083D
9/14/21 17:00
9/13/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADS.d-648.040-8-733D
4/15/21 18:43
4/12/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADM.d73.50021733D
4/15/21 18:43
4/12/21
SRNESorrento Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJanda KimCADS.d-136.970-2-393D
2/3/17 19:50
2/3/17
SRNESorrento Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiJanda KimCADP155.1513New3D-483-21-6-2-6-3-288-6-62

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact